Trends in Next-Generation Sequencing and a New Era for Whole Genome Sequencing
Level 5 - mechanism / opinion, no new human data
Narrative review/commentary on genomic sequencing technologies; Level 5 by CEBM rules.
OpenAlex W2558202273 · doi:10.5213/inj.1632742.371
What was done
This paper provides a narrative overview of technological developments and applications in next-generation sequencing (NGS) and whole-genome sequencing (WGS), discussing large-scale DNA resequencing, transcriptome analysis, epigenetic profiling, and their roles in medical genomics.
What was found
The abstract reports no numerical data or quantitative outcomes. It describes the shift from hybridization-based microarrays to sequencing-based transcriptome and epigenetic assays (such as whole-genome methylation and ChIP-seq) and highlights how NGS enables the creation of reference genome databases to support personalized and precision medicine.
Why it matters
It contextualizes how ongoing drops in cost and increases in sequencing capacity have shifted human genetics toward comprehensive whole-genome analysis for clinical applications.
Limits
The abstract describes a broad narrative commentary without primary empirical data, systematic literature search methods, or quantitative comparisons between sequencing platforms.
Cited by
- supports The cost of whole genome sequencing has dropped from approximately one billion dollars historically to around $300.